Voloridge Investment Management
TPTX

Voloridge Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Voloridge Investment Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-209,355
Closed -$15.8M – 1684
2022
Q2 		$15.8M Buy
209,355
+3,608
+2% +$160K 0.08% 322
2022
Q1 		$5.52M Buy
205,747
+58,795
+40% +$1.98M 0.03% 603
2021
Q4 		$7.01M Buy
146,952
+81,668
+125% +$3.65M 0.04% 587
2021
Q3 		$4.34M Sell
65,284
-36,725
-36% -$2.62M 0.03% 736
2021
Q2 		$7.96M Buy
102,009
+74,394
+269% +$5.5M 0.06% 479
2021
Q1 		$2.61M Buy
27,615
+20,737
+301% +$2.47M 0.02% 726
2020
Q4 		$838K Sell
6,878
-52,481
-88% -$5.75M 0.01% 1017
2020
Q3 		$5.19M Buy
+59,359
New +$4.14M 0.04% 432
2020
Q1 		– Sell
-15,478
Closed -$964K – 1496
2019
Q4 		$964K Buy
+15,478
New +$736K 0.02% 662

Voloridge Investment Management's TPTX Position: Q3 2022 in Review

Voloridge Investment Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 209,355 shares — an estimated $15.8M sold.

Voloridge Investment Management first reported a position in TPTX in Q4 2019 and held it in 9 quarters. The position peaked at $15.8M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Voloridge Investment Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 209,355 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $15.8M.
  • Voloridge Investment Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
  • Voloridge Investment Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $15.8M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.